A vaccine against SarsCov2 being developed in India, that doesn’t need to be stored in refrigerators or a cold-chain storage, generated a significant number of antibodies in mou se trials against prevalent variants of the virus.
The ‘warm’ vaccine developed by the Bengaluru-based Mynvax laboratories which is a company incubated at the Indian Institute of Science Bangalore.
The ‘warm’ vaccine can be stored at 37 degree Celsius for four weeks and at 100 degree Celsius for upto 90 minutes.
Most other vaccines require to be stored in refrigerators and can be kept at room temperature for no more than a few hours.
Scientists around the world are working on developing heat-tolerant vaccines.
A new ‘warm’ vaccine that does not require refrigeration.
Results have shown a strong immune response in mice to SARS-CoV-2, the virus that causes COVID-19.
Please Rate this article, so that we can improve the quality for you -